Peter Goodhand

The Global Alliance for Genomics & Health is an organization that creates standards and tools for the genomics and health community. The non-profit company is based in Toronto, Canada. All of their products go through an approval process before being adopted. The Canadian company offers implementations of their products and showcase how they solve real problems for organizations worldwide. The goal of the organization is to unlock the power of genomic data to benefit human health.

Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023.

The Health Technology Exchange provides non-dilutive project financing to the medical and assistive technology sector. The company’s programs include Health Technology Commercialization Program (HTCP), REACH Innovation Procurement program and MedTech ecosystem support activities. Its initiatives include The Harmony Project, The HTX Soft Landing Program and Medtech RISE. The company was founded in 2004 and is headquartered in Toronto, Canada.

Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.

The Canadian Cancer Society operates as a non-profit organization that provides cancer charity services. It offers support and services and programs for the prevention and screening of cancer. The company was founded in 1938 and is headquartered in Toronto, Canada.